Showing results (241-250 of 276) with videos related to
Sort By:
Pageof 28
Nature Communications|August 2, 2024
Controlled interconversion of macrocyclic atropisomers via defined intermediatesXin Sun, Jin-Ku Bai, Yu-Dong Yang, et al.Ebiomedicine|June 25, 2024
Optimal use of β-lactams in neonates: machine learning-based clinical decision support systemBo-Hao Tang, Bu-Fan Yao, Wei Zhang, et al.British Journal of Clinical Pharmacology|April 4, 2025
Machine learning approach for dosage individualization of azithromycin in children with community-acquired pneumoniaBo-Hao Tang, Shu-Meng Fu, Li-Yuan Tian, et al.Journal of Gastrointestinal Cancer|March 27, 2025
A Novel Diagnostic Model of Biomarkers in the Washing Fluid Obtained by EUS-FNA in Pancreatic CancerChen-Fan Li, Lan-Xiang Hao, Yi-Jia Chen, et al.Investigational New Drugs|May 16, 2020
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatmentJean-Pierre Delord, Guillem Argilés, Jerôme Fayette, et al.Science (New York, N.Y.)|July 25, 2009
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paragangliomaHuai-Xiang Hao, Oleh Khalimonchuk, Margit Schraders, et al.Journal of Clinical Pharmacology|March 18, 2024
Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic AnemiaWei Zhang, Li-Xian Chang, Bei-Bei Zhao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2019
Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET ActivationSabrina Baltschukat, Barbara Schacher Engstler, Alan Huang, et al.British Journal of Clinical Pharmacology|February 21, 2020
Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemiaYue Zhou, Li Wang, Xiao-Ying Zhai, et al.The Journal of Antimicrobial Chemotherapy|September 23, 2025
Population pharmacokinetics and dosing optimization of cefoselis in paediatric patients with haematological malignanciesJing-Rui Liu, Shu-Meng Fu, Totsapol Jirasomprasert, et al.Pageof 28